The Food and Drug Administration (FDA) yesterday cleared for marketing a prescription smartphone app...

Naltrexone is a proven treatment for opioid use disorder (OUD), but its clinical usefulness, when ta...

A bipartisan legislative package passed yesterday by Congress takes many important steps toward comb...

Several medications approved to treat alcohol and opioid use disorders also appear to reduce suicida...

The Food and Drug Administration (FDA) has approved Sublocade, the first once-monthly injectable bup...

Extended-release naltrexone and sublingual buprenorphine-naloxone appear to be equally safe and effe...